Q4 results today: Swiggy, Dr Reddy's among 68 companies to announce earnings on Friday

Synopsis

The earnings season is gaining speed. Swiggy anticipates steady revenue growth, driven by quick commerce and food delivery. However, profitability may face pressure. Losses could widen. Dr Reddy's is projected to report a net profit increase. Revenue from operations is also expected to grow. Several other companies, including ABB India and Bank of India, will also announce their results.

The fourth quarter earnings season is picking up momentum and on Friday as many as 68 companies will announce their quarterly numbers. Key earnings to watch out include from Swiggy and Dr Reddy's.

Apart from the above, ABB India, Aditya Consumer Marketing, Bank of India, Birla Corp, Dhanlaxmi Bank, FGP, GRP, KPR Mill, Lloyds Enterprises, CE Info Systems among others will also declare their results.

Swiggy Q4 expectations

Food delivery company Swiggy is expected to report steady revenue growth for the fourth quarter of FY25, driven by continued strength in its quick commerce (Instamart) and food delivery businesses. However, profitability is likely to remain under pressure due to high operating costs, particularly in the Instamart segment, which continues to require significant investments.

The company’s consolidated revenue is projected to rise 26% year-on-year (YoY), supported by a sharp increase in order volumes for both food delivery and Instamart. Meanwhile, losses are likely to widen up to Rs 1031 crore.

The company’s aggressive focus on customer acquisition, coupled with rising delivery and promotional costs, is expected to impact profitability. Swiggy’s operational metrics in the quarter may also reflect the impact of seasonal demand, with an uptick in food delivery orders but at a high customer acquisition cost.

According to Motilal Oswal, Swiggy is likely to report a revenue of Rs 4,227 crore, driven by robust order growth in its food delivery business. However, the brokerage expects the company’s losses to widen as a result of higher discounts, increased delivery costs, and elevated marketing expenses.

Dr Reddy's Q4 Preview

Pharma major Dr Reddy’s Laboratories will announce its Q4FY25 earnings on Friday where the company is expected to report a net profit growth of 1.3% to 12% on the year-on-year basis, according to estimates given by four brokerages. The bottom line is likely to be reported in the range of Rs 1,324 crore to Rs Rs 1,439 crore.

The revenue from operations in the January-March quarter of FY25 is expected to grow by 13%-18% with topline pegged in the zone of Rs 7,981 crore to Rs 8,424 crore.

The estimates have been given by Nuvama Institutional Equities, Axis Securities, Yes Securities and Equirus Securities.

(Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of Economic Times)

...moreless

...moreless